Page last updated: 2024-10-23

atenolol and Acidosis, Renal Tubular Type IV

atenolol has been researched along with Acidosis, Renal Tubular Type IV in 1 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research Excerpts

ExcerptRelevanceReference
"Hypoaldosteronism is a clinical condition resulting from inadequate stimulation of aIdosterone secretion (hyporeninemic hypoaIdosteronism), defects in adrenal synthesis of aldosterone (hyperreninemic hypoaldosteronism), or resistance to the peripheral action of this hormone (pseudohypoaldosteronism)."1.38[Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2]. ( Krysiak, R; Okopień, B, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krysiak, R1
Okopień, B1

Other Studies

1 other study available for atenolol and Acidosis, Renal Tubular Type IV

ArticleYear
[Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:4

    Topics: Adult; Atenolol; Female; Fludrocortisone; Humans; Hypoaldosteronism; Ibuprofen; Mineralocorticoids;

2012